- Home
- RDW vs PRTA Comparison
RDW vs PRTA Comparison
Compare RDW & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDW
- PRTA
- Stock Information
- Founded
- RDW 2020
- PRTA 2012
- Country
- RDW United States
- PRTA Ireland
- Employees
- RDW N/A
- PRTA N/A
- Industry
- RDW Military/Government/Technical
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- RDW Industrials
- PRTA Health Care
- Exchange
- RDW Nasdaq
- PRTA Nasdaq
- Market Cap
- RDW 800.5M
- PRTA 643.0M
- IPO Year
- RDW N/A
- PRTA N/A
- Fundamental
- Price
- RDW $13.93
- PRTA $15.22
- Analyst Decision
- RDW Strong Buy
- PRTA Buy
- Analyst Count
- RDW 5
- PRTA 7
- Target Price
- RDW $10.95
- PRTA $46.50
- AVG Volume (30 Days)
- RDW 878.1K
- PRTA 711.4K
- Earning Date
- RDW 11-06-2024
- PRTA 02-13-2025
- Dividend Yield
- RDW N/A
- PRTA N/A
- EPS Growth
- RDW N/A
- PRTA N/A
- EPS
- RDW N/A
- PRTA N/A
- Revenue
- RDW $298,026,000.00
- PRTA $133,350,000.00
- Revenue This Year
- RDW $28.47
- PRTA $57.82
- Revenue Next Year
- RDW $18.23
- PRTA N/A
- P/E Ratio
- RDW N/A
- PRTA N/A
- Revenue Growth
- RDW 27.35
- PRTA N/A
- 52 Week Low
- RDW $2.68
- PRTA $11.70
- 52 Week High
- RDW $15.25
- PRTA $41.55
- Technical
- Relative Strength Index (RSI)
- RDW 61.81
- PRTA 52.02
- Support Level
- RDW $12.27
- PRTA $11.70
- Resistance Level
- RDW $14.09
- PRTA $17.66
- Average True Range (ATR)
- RDW 1.25
- PRTA 1.46
- MACD
- RDW -0.09
- PRTA 0.20
- Stochastic Oscillator
- RDW 84.94
- PRTA 59.06
About RDW Redwire Corporation
Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's Heritage plus Innovation strategy enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).